We are leading manufacturer of In Vitro Diagnostics (IVD) in China with headquarters and manufacturing facility in Beijing. Our company- WANTAI Biological and Pharmacy Enterprise was established in 1992 as a laboratory and by now we have market-share of 35% in the Chinese IVD market. Our main production and research are focused on infectious diseases diagnostic kits, both ELISA and Rapid Test and we have developed several products, which are used in many major blood banks, disease prevention centers, and hospitals in China
Wantai's international sales strategy is implemented through third-party distributors and until now Wantai is enjoying substantial international market growth with international sales in over 20 countries worldwide. Due to the varieties in our customer's requirements, we have developed flexible production system that helps us to fulfill any client's specific requirement and provide either finished diagnostic kits or supply raw materials for production of ELISA kits and Rapid Tests
In year 2000, our manufacturing facility was a GMP certified from The State Drug Administration of China as a recognition for our quality control and management systems. Until than we have gone trough several changes in our management, production, quality and research systems and now we believe that our products can well match the foreign equivalents for quality and service.
At present, Wantai's offices, laboratories, and manufacturing facilities are situated in 3000 square meters building located in Changping Science Park- north of Beijing. To meet the challenges of the large and developing medical diagnostics industry in the 21st century, in late 2005 the company will relocates its headquarters in a new, state of the art building occupying 20 000 square meters- the largest and most advanced of its kind in China. Based on ISO and EN Quality Systems, this new headquarters will offer unique opportunities for creative researches and manufacture of high quality immunodiagnostic products and recombinant vaccines. In coming years, with the help of the current strong technology platform, solid financial backing and market experience, Wantai will transform itself into a leading, top-class IVD and vaccine company offering the most comprehensive package of services starting from basis research and manufacturing to post-marketing support.
In 1999 and in 2003 our company was the first Chinese manufacturer to whom was issued a license and certificate for HIV 1/2 ELISA and Rapid Test respectively. This event was reported in several Chinese newspapers and our company was appointed as a center for innovative research and development in the fields of Biotechnology.